Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan

NCT03084965 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1987

Last updated 2019-02-26

No results posted yet for this study

Summary

Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan.

Conditions

  • Type II Diabetes Mellitus

Sponsors & Collaborators

Eligibility

Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-12
Primary Completion
2018-03-02
Completion
2018-03-02

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03084965 on ClinicalTrials.gov